{"id":5323,"date":"2023-07-13T08:30:52","date_gmt":"2023-07-13T06:30:52","guid":{"rendered":"https:\/\/amoeba-nature.com\/?p=5323"},"modified":"2023-07-13T08:39:03","modified_gmt":"2023-07-13T06:39:03","slug":"regulatory-timetable-for-europes-biocontrol-application-on-track","status":"publish","type":"post","link":"https:\/\/amoeba-nature.com\/en\/regulatory-timetable-for-europes-biocontrol-application-on-track\/","title":{"rendered":"Regulatory timetable for Europe’s biocontrol application on track"},"content":{"rendered":"
\n

AMOEBA: Regulatory timetable for Europe’s biocontrol application on track<\/h1>\n<\/div><\/div><\/div>\n\n
\n

Chassieu (France), July 13th<\/sup>, 2023 – 08h30 –<\/strong> AMO\u00c9BA (FR0011051598 \u2013 ALMIB)<\/strong> an industrial biotech in pre-commercialization* specialized in the treatment of microbiological risk, developing a biocontrol agent for the treatment of plants in agriculture and a biological biocide for the treatment of industrial water, confirms that the regulatory timetable for the biocontrol active substance application is in line with the Company’s forecasts.<\/p>\n<\/div><\/div><\/div>\n\n

\n

The EFSA, the European Food Safety Agency, mentions on its website<\/a> a Risk Assessment Deadline on July 19, 2023. As this date was assigned by default when the peer-review <\/a>of dossier was initiated in December 2022, it does not take into account any delay by the authorities.<\/p>\n<\/div><\/div><\/div>\n\n

\n

The Company had anticipated this possible delay in its forecasts: the regulatory timetable for its biocontrol applications in Europe, as published in the Universal Registration Document 2022<\/a> filed with the AMF on April 18, 2023 under the number D23-0296 and available on the Company’s website, is still valid and is recalled below:<\/p>\n<\/div><\/div><\/div>\n\n

\n